RGD Reference Report - Alpha2-antiplasmin plays a significant role in acute pulmonary embolism. - Rat Genome Database

Send us a Message

Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Alpha2-antiplasmin plays a significant role in acute pulmonary embolism.

Authors: Matsuno, H  Okada, K  Ueshima, S  Matsuo, O  Kozawa, O 
Citation: Matsuno H, etal., J Thromb Haemost. 2003 Aug;1(8):1734-9.
RGD ID: 1580302
Pubmed: (View Article at PubMed) PMID:12911586

The importance of pulmonary embolism (PE) due to venous thrombosis is recognized in the treatment of vascular diseases. We have investigated the physiological effects of plasmin generation in experimental acute PE using mice deficient in plasminogen (Plg-/-) or alpha2-antiplasmin (alpha2-AP-/-). PE was induced by continuous induction of venous thrombus in the left jugular vein by endothelial injury due to photochemical reaction. The mortality of wild-type mice was 68.8% at 2 h after the initiation of venous thrombosis and it was significantly reduced in alpha2-AP-/- mice (41.7%). In contrast, Plg-/- mice did not survive. Histological evidence of thromboembolism in the lung was obtained in all mice. However, whereas a strict thromboembolism was observed in Plg-/- mice, only a few thrombi were detected in the lungs of alpha2-AP-/- mice. Plasma fibrinogen levels measured in mice were not different. When alpha2-AP was infused in alpha2-AP-/- mice, the mortality was indistinguishable from wild-type mice. Tissue-type plasminogen activator (tPA) did not reduce the mortality due to acute PE in wild-type mice. However, in alpha2-AP-/- mice, tPA (0.52 mg x kg-1) significantly decreased the mortality compared with that of alpha2-AP-/- mice without tPA. The bleeding time was not significantly prolonged in either type of mice treated with tPA. The lack of plasminogen increases the mortality due to acute PE while a lack of alpha2-AP decreases the mortality rate, which can be further reduced by tPA administration. Therefore, the combination of inhibition of alpha2-AP with thrombolytic therapy could be beneficial in the treatment of acute PE.


Disease Annotations    
pulmonary embolism  (IMP,ISO)

Objects Annotated

Genes (Rattus norvegicus)
Serpinf2  (serpin family F member 2)

Genes (Mus musculus)
Serpinf2  (serine (or cysteine) peptidase inhibitor, clade F, member 2)

Genes (Homo sapiens)
SERPINF2  (serpin family F member 2)

Additional Information